Royal Bank of Canada
GH icon

Royal Bank of Canada’s Guardant Health GH Stock Holding History

Royal Bank of Canada’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,000
Closed -$4.26M – 7132
2025
Q1 		$4.26M Buy
+100,000
New +$4.31M ﹤0.01% 2374
2021
Q3 		– Sell
-22,600
Closed -$2.81M – 7709
2021
Q2 		$2.81M Sell
22,600
-800
-3% -$108K ﹤0.01% 2772
2021
Q1 		$3.57M Buy
+23,400
New +$3.54M ﹤0.01% 2508

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada's GH Position: Q1 2026 in Review

Royal Bank of Canada increased its Guardant Health (GH) stake by 2.8% in Q1 2026, buying an estimated $398K and bringing the position to 146,404 shares worth $13.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

Royal Bank of Canada first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $46.5M in Q2 2025. 483 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Royal Bank of Canada held 146,404 shares of Guardant Health worth $13.5M as of Q1 2026.
  • Royal Bank of Canada bought 3,962 Guardant Health shares in Q1 2026, an estimated $398K.
  • Guardant Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1711 holding.
  • Royal Bank of Canada first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
  • Royal Bank of Canada's Guardant Health position peaked at $46.5M in Q2 2025.
  • 483 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.